In human ALS participants recruited in this study, we found that dosing with primidone reduced the serum levels of RIPK1 and IL-8, which were significantly higher in ALS patients than that of healthy individuals. This evidence concerns the gene CXCL8 and amyotrophic lateral sclerosis.